AD PHARMA CONSULTING LIMITED

Company number 07468413 ·

Active

Net assets, total assets & total liabilities 2016 – 2024

  • Total assets
  • Net assets
  • Total liabilities
-£300k -£200k -£100k £0 £100k £200k £300k 2016 2017 2018 2019 2020 2021 2022 2023 2024 Total assets 2018: £139,733 Total assets 2019: £139,478 Total assets Net assets 2016: £181,975 Net assets 2017: £161,851 Net assets 2018: £107,042 Net assets 2019: £102,872 Net assets 2020: £119,249 Net assets 2021: £141,906 Net assets 2022: £117,543 Net assets 2023: £230,077 Net assets 2024: £299,081 Net assets Total liabilities 2016: -£64,859 Total liabilities 2017: -£111,546 Total liabilities 2018: -£136,923 Total liabilities 2019: -£201,626 Total liabilities 2020: -£182,860 Total liabilities 2021: -£129,615 Total liabilities 2022: -£294,001 Total liabilities 2023: -£163,631 Total liabilities 2024: -£182,737 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2023 – 2024

0 0 0 0 1 1 1 1 2 2023 2024 2023: 2 2024: 2

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 9 years

Latest accounts (2024-11-30): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2024-11-30 -£182,737 £299,081 £30,775 2
2023-11-30 -£163,631 £230,077 £6,446 2
2022-11-30 -£294,001 £117,543 £6,096
2021-11-30 -£129,615 £141,906 £11,250
2020-11-30 -£182,860 £119,249 £26,443
2019-11-30 £139,478 -£201,626 £102,872 £42,114
2018-11-30 £139,733 -£136,923 £107,042 £11,859
2017-11-30 -£111,546 £161,851 £16,920
2016-11-30 -£64,859 £181,975

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.

Debt & working capital 2024-11-30

Owed to suppliers
£10,518